- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06049511
Oral Self Care Protocol and Oral Mucositis (OSCP and OM)
The Effect of the Oral Self-Care Protocol on Mucositis and Self-Care Agency According to Orem's Self-Care Deficiency Theory in Patients With Hematologic Malignancies Receiving High-Dose Chemotherapy: A Randomized Controlled Study
Objective: This study was conducted in order to examine the effect of oral self-care protocol based on Orem's Self-Care Deficiency Theory on oral mucositis and self-care agency.
Method: This study was conducted as a randomized controlled trial between August 2021 and July 2022, patients with hematological malignancies receiving high-dose chemotherapy at the Izmir Ege University Faculty of Medicine Hospital and Izmir Training and Research Hospital. The sample of the study consisted of a total of 60 patients, including 30 application groups and 30 control groups, who met the inclusion criteria using the computer-based stratified randomization method. The study data were collected using "Patient Information Questionnaire," "WHO-Oral Mucositis Toxicity Scale," "Oral Assessment Guide," "Self-Care Agency Scale," "Data Collection Form Prepared According to Orem's Self-Care Deficiency Nursing Theory," "Oral Care Chart," and "Oral Cavity Photography." The oral self-care protocol, which includes training and oral care practices, was applied to the application group for 21 days from the beginning of chemotherapy treatment. The control group was not subjected to any oral care attempts by the researcher and received standard nursing care in the clinic. The data were evaluated by descriptive statistics, the Chi-square test, the Mann-Whitney U test, the Mc Ne-mar test, the Kappa compliance test, and the t test in dependent and independent groups. Keywords: chemotherapy; hematological malignancy; oral mucositis; oral self-care protocol; Orem's theory; self-care agency; nursing
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Bornova
-
İzmir, Bornova, Turkey
- Ege University Medical Faculty Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Willing to participate,
- Have the ability to read and write,
- Volunteer for oral cavity photography,
- Possess a platelet value above 20,000/mm3, and
- Have intact oral mucous membrane integrity.
Exclusion Criteria:
- Who received combined radiotherapy and chemotherapy treatments
- Had incomplete questionnaire responses.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: intervention group
An oral self-care protocol, grounded in Orem's Self-Care Deficit theory and incorporating self-care behaviors, was implemented for the patients in the treatment group.
The protocol consisted of several components, including the assessment of oral mucositis by the researcher and self-assessment of the oral cavity by the patients.
It also involved oral care, teaching proper tooth brushing techniques, providing written materials, supplying an oral care kit, and offering patient and family education.
|
An oral self-care protocol, grounded in Orem's Self-Care Deficit theory and incorporating self-care behaviors, was implemented for the patients in the treatment group.
The protocol consisted of several components, including the assessment of oral mucositis by the researcher and self-assessment of the oral cavity by the patients.
It also involved teaching proper tooth brushing techniques, providing written materials, supplying an oral care kit, and offering patient and family education.
Interventions were made for 21 days from the beginning of chemotherapy treatment.
|
|
Other: control group
The control group consisted of a total of 30 patients who met the selection criteria, willingly participated in the study, and were randomly assigned based on a predetermined randomization list.
In the control group, the investigator did not administer any specific oral care intervention.
Instead, the patients received standard nursing care provided at the clinic to prevent oral mucositis.
Moreover, all patients in the control group were given the same mouthwashes (Benzydamine and Mycostatin) as those in the treatment group.
However, the frequency and timing of oral care varied among the nurses in the clinic due to differences in work load and individual experience.
|
the patients received standard nursing care provided at the clinic to prevent oral mucositis.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
World Health Organization Oral Mucositis Toxicity Scale
Time Frame: 21 days
|
to assess oral mucositis severity.
The World Health Organization (WHO) classifies oral mucositis into different grades: grade 0 indicates no issues with the oral mucosa; grade 1 signifies mild local changes such as erythema and inflammation, with the ability to consume oral food; grade 2 involves mild pain, along with erythema, edema, inflammation, or ulcers, allowing unrestricted eating; grade 3 denotes painful erythema, edema, or ulcers without bleeding, necessitating a liquid food diet; and grade 4 represents extensive mucositis, severe pain, and bleeding, rendering oral feeding impossible.
|
21 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oral assessment guide
Time Frame: 21 days
|
assess their oral condition on a daily basis and serves as a valuable tool for monitoring the progression of mucositis and evaluating the effectiveness of treatment.
This guide encompasses eight categories: voice, swallowing, lips, tongue, saliva, mucous membranes, gums, and teeth or dentures.
Each category is assigned numerical values of 1, 2, or 3, representing normal findings (1 point) to severe findings (3 points).
The cumulative score for all eight categories ranges from 8 points, indicating normal findings, to 24 points, denoting severe changes.
A higher score indicates an increased risk of developing mucositis.
|
21 days
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Scientific Research Project
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mucositis Oral
-
Instituto Nacional de Cancer, BrazilWithdrawnOral Mucositis | Oral Mucositis (Ulcerative) Due to Radiation | Oral Mucositis (Ulcerative) Due to Antineoplastic Therapy | Oral Mucositis Due to RadiationBrazil
-
Air Force Military Medical University, ChinaCompletedMucositis OralChina
-
Ain Shams UniversityCompletedOral Mucositis | Radiation Induced Oral Mucositis | Oral Mucositis Due to RadiationEgypt
-
University Hospital, ToulouseRecruiting
-
Catalysis SLCompletedMucositis OralRussian Federation
-
Ghada zakiNot yet recruiting
-
Ain Shams UniversityNot yet recruitingOral Mucositis Due to ChemotherapyEgypt
-
Zubeyde Ezgi ErcelikCompleted
-
Galera Therapeutics, Inc.CompletedRadiation Induced Oral MucositisUnited States, Canada, Puerto Rico
-
Cairo UniversityNot yet recruitingChemotherapy Induced Oral Mucositis
Clinical Trials on oral self care protocol
-
VA Office of Research and DevelopmentCompleted
-
Mackay Memorial HospitalNational Taiwan UniversityCompleted
-
The University of Texas at Arlington59th Medical Wing; The University of Texas Health Science Center at San Antonio and other collaboratorsCompletedChronic Pain | Post-traumatic Stress DisorderUnited States
-
Aminu Kano Teaching HospitalNIH Office of AIDS Research (OAR); Fogarty International Center of the National...CompletedQuality of Life | Dental Caries | HIV | Oral Disease | Oral Infection | Oral ManifestationsNigeria
-
Fraser HealthCompleted
-
Aalborg UniversityCompleted
-
University of PaviaCompleted
-
Zubeyde Ezgi ErcelikCompleted
-
HSIN LING CHENNational Taipei University of Nursing and Health SciencesRecruiting
-
University of the Balearic IslandsMinisterio de Economía y Competitividad, SpainCompleted